Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. (Q27319831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

title

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

3 April 2020

main subject

0 references

author

Judyta Juranek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

Huilin Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

8

Ann Marie Schmidt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Gurdip K Daffu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

Matthew S Geddis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

Rosa Rosario

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

Benjamin J Kaplan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

Lauren Kelly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

9 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

Frontiers in Cellular Neuroscience

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

3 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

A practical guide to understanding Kaplan-Meier curves

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Nonparametric Estimation from Incomplete Observations

21 March 2017

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Assessing functional performance in the mdx mouse model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Effect of TTP488 in patients with mild to moderate Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Soluble forms of RAGE in internal medicine.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Evaluation of rage isoforms, ligands, and signaling in the brain.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Understanding survival analysis: Kaplan-Meier estimate

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4860390

Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging

31 May 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100beta expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Blocking the Receptor for Advanced Glycation End Product Activation Attenuates Autoimmune Myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FNCEL.2016.00117

Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS

21 January 2018

1 reference

12 December 2020

Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing

1 reference

12 December 2020

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

12 December 2020

Sexual differences in onset of disease and response to exercise in a transgenic model of ALS

1 reference

12 December 2020

Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS

1 reference

12 December 2020

Identifiers

DOI

10.3389/FNCEL.2016.00117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

3 April 2020

1774391

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1774391

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27242430 AND SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

27242430

1 reference